Eagle Asset Management Inc Insmed Inc Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 263,235 shares of INSM stock, worth $20.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

263,235

Previous 314,690 16.35%

Holding current value

$20.3 Million

Previous $21.1 Million 8.86%

% of portfolio

0.11%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$62.0 - $79.01 $3.19 Million - $4.07 Million	-51,455 Reduced 16.35%	263,235 $19.2 Million
Q2 2024 Aug 12, 2024	SELL	$22.0 - $69.71 $4.61 Million - $14.6 Million	-209,682 Reduced 39.99%	314,690 $21.1 Million
Q1 2024 May 09, 2024	SELL	$25.72 - $29.94 $623,992 - $726,374	-24,261 Reduced 4.42%	524,372 $14.2 Million
Q4 2023 Feb 12, 2024	BUY	$23.42 - $31.74 $692,178 - $938,075	29,555 Added 5.69%	548,633 $17 Million
Q3 2023 Nov 13, 2023	SELL	$19.86 - $26.93 $184,022 - $249,533	-9,266 Reduced 1.75%	519,078 $13.1 Million
Q2 2023 Aug 09, 2023	BUY	$16.44 - $21.1 $2.17 Million - $2.78 Million	131,976 Added 33.3%	528,344 $11.1 Million
Q1 2023 May 08, 2023	SELL	$16.26 - $21.73 $5.12 Million - $6.84 Million	-314,897 Reduced 44.27%	396,368 $6.76 Million
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $485,899 - $662,460	-28,616 Reduced 3.87%	711,265 $14.2 Million
Q3 2022 Nov 07, 2022	SELL	$20.88 - $28.21 $256,176 - $346,108	-12,269 Reduced 1.63%	739,881 $15.9 Million
Q2 2022 Aug 10, 2022	SELL	$17.07 - $25.71 $1.54 Million - $2.32 Million	-90,321 Reduced 10.72%	752,150 $14.8 Million
Q1 2022 May 12, 2022	SELL	$20.42 - $28.13 $794,317 - $1.09 Million	-38,899 Reduced 4.41%	842,471 $19.8 Million
Q4 2021 Feb 11, 2022	SELL	$25.89 - $33.45 $1.29 Million - $1.67 Million	-49,843 Reduced 5.35%	881,370 $24.1 Million
Q3 2021 Nov 10, 2021	SELL	$22.46 - $29.47 $2.3 Million - $3.02 Million	-102,345 Reduced 9.9%	931,213 $25.6 Million
Q2 2021 Aug 11, 2021	BUY	$24.17 - $36.01 $366,948 - $546,703	15,182 Added 1.49%	1,033,558 $29.4 Million
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $6.25 Million - $8.57 Million	-193,482 Reduced 15.97%	1,018,376 $36.1 Million
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $4.4 Million - $5.67 Million	-139,962 Reduced 10.35%	1,211,858 $40.3 Million
Q3 2020 Nov 12, 2020	SELL	$26.0 - $34.5 $2.1 Million - $2.79 Million	-80,870 Reduced 5.64%	1,351,820 $44.3 Million
Q2 2020 Aug 12, 2020	SELL	$14.11 - $29.42 $983,833 - $2.05 Million	-69,726 Reduced 4.64%	1,432,690 $38.5 Million
Q1 2020 May 11, 2020	SELL	$13.63 - $33.98 $144,014 - $359,032	-10,566 Reduced 0.7%	1,502,416 $24.1 Million
Q4 2019 Feb 07, 2020	SELL	$16.12 - $24.98 $190,473 - $295,163	-11,816 Reduced 0.77%	1,512,982 $36.1 Million
Q3 2019 Nov 04, 2019	BUY	$15.49 - $25.78 $359,987 - $599,127	23,240 Added 1.55%	1,524,798 $26.9 Million
Q2 2019 Aug 05, 2019	BUY	$23.0 - $32.19 $34.5 Million - $48.3 Million	1,501,558 New	1,501,558 $38.4 Million

Others Institutions Holding INSM

# of Institutions

498

Shares Held

189M

Call Options Held

3.21M

Put Options Held

2.72M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.5B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Insmed Inc Transaction History